Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Vandalia Research has received $1.04m contract from the US Department of Defense for 'Flu Vaccine Technology Program.'
Subscribe to our email newsletter
The program aims for scale-up and pre-clinical development of pandemic flu vaccine produced by Vandalia’s PCR process utilizing Triathlon bioreactor.
The contract will be executed in partnership with Richard Heller of the Frank Reidy Research Center for Bioelectrics at Old Dominion University in Norfolk, Virginia and director of Center for Predictive Medicine, Colleen Jonsson, at the University of Louisville.
Vandalia CEO Derek Gregg said this contract lends validation to their efforts to develop a scalable new method to develop and manufacture vaccines.